This bill modifies the Maine Health Data Organization's board of directors, changing its size and composition.
This bill changes the size and composition of the Maine Health Data Organization's board of directors. It increases the board from 14 to 15 members, including 14 voting members and one nonvoting member. The board now includes representatives from the pharmaceutical industry, a statewide purchasing coalition, and the executive director of the organization. It also modifies the terms of the board members, with initial terms staggered and subsequent terms set at three years. The bill removes the provision regarding the staggering of initial terms.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.